COMMUNIQUÉS West-GlobeNewswire

Celldex Therapeutics Announces Pricing of Upsized $400 Million Public Offering of Common Stock

01/03/2024 - 03:14

HAMPTON, N.J., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (“Celldex” or the “Company”) (Nasdaq: CLDX) today announced the pricing of an upsized underwritten public offering of 8,520,000 shares of its [...]

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

01/03/2024 - 01:05

ALISO VIEJO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, [...]

CORRECTION - Theratechnologies annonce la démission de l’un de ses administrateurs, M. Alain Trudeau

29/02/2024 - 23:40

MONTRÉAL, 29 févr. 2024 (GLOBE NEWSWIRE) -- Aujourd’hui, Theratechnologies Inc. (TSX : TH) (NASDAQ : THTX) a diffusé un communiqué de presse que le présent document sous le même titre corrige et remplace. Veuillez noter [...]

Scilex Holding Company Announces $10 Million Bought Deal Offering

29/02/2024 - 23:32

PALO ALTO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

Spectral AI Appoints Peter M. Carlson as CEO

29/02/2024 - 23:30

Appointment Paves the Way for Company’s Next Chapter in Commercialization Phase of AI-Powered DeepView Device for Predictive Wound Care Carlson Brings Proven Track Record of Operating and Financial Leadership, Including [...]

Arcutis to Present at the TD Cowen 44th Annual Health Care Conference

29/02/2024 - 23:00

WESTLAKE VILLAGE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency

29/02/2024 - 23:00

Complete Pre-TCRα Deficiency Found to be Very Rare, Partial Form More Common Than Expected CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company [...]

Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results

29/02/2024 - 22:40

Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time YARDLEY, Pa., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose [...]

Tarsus Announces Proposed $100.0 Million Public Offering

29/02/2024 - 22:37

IRVINE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”), whose mission is to focus on unmet needs and apply proven science and new technology to [...]

Theratechnologies Announces the Resignation of One of Its Directors, Mr. Alain Trudeau

29/02/2024 - 22:34

MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of [...]

Theratechnologies annonce la démission de l’un de ses administrateurs, M. Alain Trudeau

29/02/2024 - 22:34

MONTRÉAL, 29 févr. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise au point et la commercialisation [...]

Nephros Schedules Conference Call for Fourth Quarter and Fiscal Year 2023 Financial Results

29/02/2024 - 22:30

SOUTH ORANGE, NJ, Feb. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today [...]

Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference

29/02/2024 - 22:30

EMERYVILLE, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its propri [...]

Nyxoah to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

29/02/2024 - 22:30

Nyxoah to Participate in the Oppenheimer 34 th Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgium – February 29, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“ [...]

Nyxoah Participera à la 34ème Oppenheimer Annual Healthcare MedTech & Services Conference

29/02/2024 - 22:30

Nyxoah Participera à la 34 ème Oppenheimer Annual Healthcare MedTech & Services Conference Mont-Saint-Guibert, Belgique – 29 février 2024, 22h30 CET / 16h30 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« [...]

CooperCompanies Announces First Quarter 2024 Results

29/02/2024 - 22:15

SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue [...]

GENFIT Announces Revenues and Cash Position as of December 31, 2023

29/02/2024 - 22:10

Cash and cash equivalents totaled €77.8 million as of December 31, 2023 Revenues amounted to €28.6 million as of December 31, 2023 including a milestone payment of €13.3 million Upcoming FDA PDUFA action date for [...]

GENFIT annonce son chiffre d’affaires et sa position de trésorerie au 31 décembre 2023

29/02/2024 - 22:10

Trésorerie et équivalents de trésorerie : 77,8 millions d’euros au 31 décembre 2023 Chiffre d’affaires : 28,6 millions d’euros au 31 décembre 2023, dont un paiement d’étape de 13,3 millions d’euros Date d’action PDUFA [...]

RadNet Reports Fourth Quarter 2023 Results, Including Record Revenue and Adjusted EBITDA(1), Releases 2024 Financial Guidance and Forms a New Digital Health Reporting Segment

29/02/2024 - 22:10

Revenue increased 9.5% to a record $420.4 million in the fourth quarter of 2023 from $383.9 million in the fourth quarter of 2022; Excluding Revenue from the Artificial Intelligence (“AI”) reporting segment, Revenue [...]